Exon skipping in CYBB mRNA and skewed inactivation of X chromosome cause late-onset chronic granulomatous disease

Pediatr Hematol Oncol. 2018 Aug-Sep;35(5-6):341-349. doi: 10.1080/08880018.2018.1522402. Epub 2019 Jan 11.

Abstract

Chronic granulomatous disease (CGD) is a hereditary immunodeficiency syndrome caused by a defect in the NADPH oxidase complex, which is essential for bactericidal function of phagocytes. Approximately 70% of patients with CGD have a mutation in the CYBB gene on the X chromosome, resulting in defective expression of gp91phox, one of the membrane-bound subunits of NADPH oxidase. Although most patients with X-linked CGD are males, owing to transmission of this disease as an X-linked recessive trait, there are female patients with X-linked CGD. Here, we report the case of a teenage girl with X-linked CGD associated with a heterozygous mutation in exon 5 of the CYBB gene (c.389G > C; R130P), which causes skipping of exon 5, resulting in a premature stop codon in exon 6 of CYBB. Accurate pro-mRNA splicing for mature mRNA formation is regulated by several splicing mechanisms that are essential for appropriate recognition of exonic sequences. The c.389G > C mutation disrupts exonic-splicing regulator sequences, thereby resulting in the aberrant skipping of exon 5 in the CYBB transcript of the patient. The patient showed an extremely skewed (≥96%) X inactivation pattern of the HUMARA locus; this inactivation is thought to be responsible for the development of CGD not only in neutrophils but also in monocytic, T-cell, and B-cell lineages and in CD34-positive immature hematopoietic cells. Our case and other reports indicate that the onset of X-linked CGD in female patients tends to occur later in life, and that the symptoms tend to be milder as compared to male patients.

Keywords: CYBB; Chronic granulomatous disease; X inactivation; exon skipping.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Chromosomes, Human, X / genetics*
  • Exons*
  • Female
  • Genetic Loci
  • Granulomatous Disease, Chronic* / enzymology
  • Granulomatous Disease, Chronic* / genetics
  • Granulomatous Disease, Chronic* / pathology
  • Humans
  • NADPH Oxidase 2* / genetics
  • NADPH Oxidase 2* / metabolism
  • Point Mutation*
  • RNA, Messenger* / genetics
  • RNA, Messenger* / metabolism
  • Receptors, Androgen / genetics
  • Receptors, Androgen / metabolism
  • X Chromosome Inactivation*

Substances

  • AR protein, human
  • RNA, Messenger
  • Receptors, Androgen
  • CYBB protein, human
  • NADPH Oxidase 2